Cart summary

You have no items in your shopping cart.

Lifastuzumab Biosimilar (Anti-NaPi2b / SLC34A2 Reference Antibody)

Lifastuzumab Biosimilar (Anti-NaPi2b / SLC34A2 Reference Antibody)

Catalog Number: orb2704007

Select Product Size
SizePriceQuantity
100 mg$ 3,370.00
100 mg Enquire
DispatchUsually dispatched within 5-10 working days
Product Properties
Catalog Numberorb2704007
CategoryAntibodies
DescriptionLifastuzumab is a humanized anti-NaPi2b monoclonal antibody (IgG1 type). Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) through ADC Linker to form an antibody-drug conjugate (ADC) lifastuzumab vedotin (DNIB0600A) with anticancer activity.
TargetLifastuzumab Biosimilar(Anti-NaPi2b / SLC34A2 Reference Antibody)
ClonalityMonoclonal
ConjugationUnconjugated
Antibody TypeBiosimilar Antibody
CAS Number1615697-16-9
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
NoteFor research use only
Images
Reviews

Lifastuzumab Biosimilar (Anti-NaPi2b / SLC34A2 Reference Antibody) (orb2704007)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet